Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat

Fundam Clin Pharmacol. 1998;12(1):88-94. doi: 10.1111/j.1472-8206.1998.tb00929.x.

Abstract

Trigeminal stimulation of C-fibers increased c-fos expression within the trigeminal nucleus caudalis (NtV) and thalamic neuronal activity which both reflect the transmission of a nociceptive message. We examined the effects on both these phenomena of the selective NK1 and NK2 receptor antagonists, SR140333 and SR48968. SR140333 (0.3, 1 and 3 micrograms/kg intravenously [i.v.]) dose-dependently, reversibly and stereoselectively antagonized the increase of contralateral thalamic activity. This compound, when given i.v. (30 micrograms/kg) or orally (10 mg/kg), also reduced the number of Fos-like immunoreactive cells particularly at the medial and caudal level of the NtV. In contrast, SR48968 did not exert any antagonistic effect either on thalamic activity or on Fos-like immunoreactivity. The data strongly suggest a preferential involvement of NK1 vs NK2 receptors in nociceptive transmission following trigeminal ganglion stimulation. Taken together, our results indicate that SR140333 could provide a potent drug for the relief of pain occurring under excessive activity of sensory trigeminal fibers.

MeSH terms

  • Administration, Oral
  • Animals
  • Benzamides / pharmacology
  • Electric Stimulation
  • Immunohistochemistry
  • Injections, Intravenous
  • Male
  • Neural Pathways / drug effects*
  • Neurokinin-1 Receptor Antagonists*
  • Neurons / drug effects
  • Neurons / metabolism
  • Pain / physiopathology*
  • Piperidines / administration & dosage
  • Piperidines / pharmacology*
  • Proto-Oncogene Proteins c-fos / antagonists & inhibitors
  • Quinuclidines / administration & dosage
  • Quinuclidines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Neurokinin-2 / antagonists & inhibitors
  • Thalamus / cytology
  • Thalamus / drug effects*
  • Thalamus / metabolism
  • Trigeminal Nuclei / cytology
  • Trigeminal Nuclei / drug effects*
  • Trigeminal Nuclei / metabolism

Substances

  • Benzamides
  • Neurokinin-1 Receptor Antagonists
  • Piperidines
  • Proto-Oncogene Proteins c-fos
  • Quinuclidines
  • Receptors, Neurokinin-2
  • SR 140333
  • SR 48968